Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel R Orriss

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Autonomic Neuroscience : Basic & Clinical|May 17, 2015
The role of purinergic signalling in the musculoskeletal systemIsabel R Orriss
Bone|January 20, 2020
Extracellular pyrophosphate: The body's "water softener"Isabel R Orriss
Current Opinion in Pharmacology|April 13, 2016
Editorial overview: Musculoskeletal: Where are we with treating musculoskeletal disorders?Isabel R Orriss, Vicky E MacRae
Purinergic Signalling|June 1, 2023
Editorial: Special issue on purinergic signalling and calcificationIsabel R Orriss, Timothy R Arnett
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Rodent osteoclast culturesIsabel R Orriss, Timothy R Arnett
Bone|December 25, 2017
Metabolic properties of the osteoclastTimothy R Arnett, Isabel R Orriss
Cell Biochemistry and Function|August 4, 2022
High bone mass in mice can be linked to lower osteoclast formation, resorptive capacity, and restricted in vitro sensitivity to inhibition by stable sulforaphanePolymnia Louka, Isabel R Orriss, Andrew A Pitsillides
Purinergic Signalling|August 15, 2013
Purinergic signalling in the musculoskeletal systemGeoffrey Burnstock, Timothy R Arnett, Isabel R Orriss
Current Opinion in Pharmacology|March 2, 2010
Purinergic signalling and bone remodellingIsabel R Orriss, Geoffrey Burnstock, Timothy R Arnett
Cells|January 22, 2024
Stable Sulforaphane Targets the Early Stages of Osteoclast Formation to Engender a Lasting Functional Blockade of OsteoclastogenesisPolymnia Louka, Isabel R Orriss, Andrew A Pitsillides
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Autonomic Neuroscience : Basic & Clinical|May 17, 2015
The role of purinergic signalling in the musculoskeletal systemIsabel R Orriss
Bone|January 20, 2020
Extracellular pyrophosphate: The body's "water softener"Isabel R Orriss
Current Opinion in Pharmacology|April 13, 2016
Editorial overview: Musculoskeletal: Where are we with treating musculoskeletal disorders?Isabel R Orriss, Vicky E MacRae
Purinergic Signalling|June 1, 2023
Editorial: Special issue on purinergic signalling and calcificationIsabel R Orriss, Timothy R Arnett
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Rodent osteoclast culturesIsabel R Orriss, Timothy R Arnett
Bone|December 25, 2017
Metabolic properties of the osteoclastTimothy R Arnett, Isabel R Orriss
Cell Biochemistry and Function|August 4, 2022
High bone mass in mice can be linked to lower osteoclast formation, resorptive capacity, and restricted in vitro sensitivity to inhibition by stable sulforaphanePolymnia Louka, Isabel R Orriss, Andrew A Pitsillides
Purinergic Signalling|August 15, 2013
Purinergic signalling in the musculoskeletal systemGeoffrey Burnstock, Timothy R Arnett, Isabel R Orriss
Current Opinion in Pharmacology|March 2, 2010
Purinergic signalling and bone remodellingIsabel R Orriss, Geoffrey Burnstock, Timothy R Arnett
Cells|January 22, 2024
Stable Sulforaphane Targets the Early Stages of Osteoclast Formation to Engender a Lasting Functional Blockade of OsteoclastogenesisPolymnia Louka, Isabel R Orriss, Andrew A Pitsillides
Pageof 6